NYSE: RMD
Healthcare · Medical - Devices
Market Cap
$32.04B
52w High
$293.81
52w Low
$180.27
P/E
21.02
Volume
492.80K
Outstanding Shares
145.06M
Performance
Price vs Fundamentals
The stock fell 22.8% over the last year. Revenue grew 9.85% over the trailing twelve months. Operating margin moved from 32.75% to 33.48%. Free cash flow grew 74.2% over the trailing twelve months.
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 5th percentile of their historical P/FCF range. That looks more like a rerating of the multiple than a collapse in the business.
This read changes if operating margin (currently 33.48%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions.
Valuation
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
13
Buy
17
Hold
5
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 29, 2026
Q4 FY26 · EPS est $2.74 · Revenue est $1.39B
View
Dividends
$2.46/shareQuarterlyDividend Achiever · 13yrEx-div Aug 20, 2026 · in 2dSafeRMD pays a dividend with a 1.11% declared yield, 13 consecutive years of growth, growing at 9.12% annually, covered 4.7× by free cash flow.
Declared Yield
1.11%
Annual Div / Share
$2.46
TTM $2.40
5yr CAGR
+9.12%
Doubles every ~7.9yr
Payout Ratio
40.19%
Safe
Dividend Growth Rate
3yr CAGR
+10.97%
5yr CAGR
+9.12%
10yr CAGR
+7.18%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$1/mo
In 5 yrs
$1/mo
In 10 yrs
$2/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$11/yr $1/mo | $17/yr+55% $1/mo | $27/yr+139% $2/mo |
Yield-on-cost grows from 1.11% → 2.67% over 10yr
Analysis
Dividend Achiever
RMD has raised its dividend for 13 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 4.7× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 9.12% meaningfully outpaces inflation, compounding real income growth for long-term holders.
No strong risk signal stands out from the latest period pair.